ConductScience.org, home

Gene · 11346

SYNPO: synaptopodin

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. SYNPO: synaptopodin. Genes, record 11346. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11346

On this page

Gene

Symbol
SYNPO
HGNC
Name
synaptopodin
HGNC
NCBI Gene ID
11346
NCBI Gene
HGNC ID
HGNC:30672
HGNC
Ensembl
ENSG00000171992
NCBI Gene
Aliases
KIAA1029, SYNPO1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q8N3V7Synaptopodin9290Ensembl, GeneID, HGNC

Source UniProt

Patents16

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1466061Q8N3V7Espacenet
JP 2026004568 A2026-01-1466063Q8N3V7Espacenet
WO 2025257368 A12025-12-183Q8N3V7Espacenet
EP 4641201 A22025-10-2911574Q8N3V7Espacenet
JP 2025517969 A2025-06-1211574Q8N3V7Espacenet
US 11446398 B22022-09-2085609Q8N3V7Espacenet
US 11446398 B22022-09-2085610Q8N3V7Espacenet
JP 2022524081 A2022-04-27188580Q8N3V7Espacenet
JP 2022524081 A2022-04-27188581Q8N3V7Espacenet
JP 2019054813 A2019-04-11246496Q8N3V7Espacenet

1 to 10 of 16

See all 16 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants974

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSYNPO papersNewest fiscal year
ZIAAG000975ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders82025
R01DK099465Mechanisms of disrupted homeostasis and kidney injury52025
P30DA018343Yale/NIDA Neuroproteomics Center42025
R01DK076077Adaptive and maladaptive repair after kidney injury42025
R01DK095045Molecular mechanisms of podocyte injury in FSGS42025
R01DK104753Crosstalk Between Lipid Droplets and Other Organelles in Podocytes42025
P30DK020572Michigan Diabetes Research Center (MDRC)32025
P30DK020579Diabetes Research Center32025
P30EY008126Core Grant in Vision Research32025
R01DK072381Kidney Injury Molecule-1 in Epithelial Repair32025

1 to 10 of 974Source NIH's project files

See all 974 nih grants

Papers1,462

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Inhibition of STING modulates dendritic cell responses and ameliorates podocyte injury in SLE.Lupus Sci Med202642778309PubTator, text miningPubMed
Protein endocytosis dysfunction in kidney biopsies of patients with diabetic nephropathy and minimal change disease: a pilot study on ClC-5 and the megalin receptor.J Nephrol202642543842PubTator, text miningPubMed
LncRNA GATA3-AS1-mediated miR-2116-5p interaction modulates TCF12 and contributes to podocyte dysfunction in childhood nephrotic syndrome.Clinics (Sao Paulo)202642462511PubTator, text miningPubMed
Selective JNK3 Inhibition Ameliorates TGF- β -Mediated Glomerular Injury and Fibrosis in the Kidneys.J Am Soc Nephrol202642440378PubTator, text miningPubMed
Bioinstructive Hybrid Scaffold Integrating Phosphoinositide 3-Kinase-Akt and Complementary Survival Pathways for Kidney Regeneration.ACS Nano202642400932PubTator, text miningPubMed
Urinary ANGPTL3: a novel noninvasive biomarker for podocyte injury in pediatric glomerular diseases.J Transl Med202642337674PubTator, text miningPubMed
Biallelic pathogenic variants in FLNB are associated with paediatric steroid-resistant nephrotic syndrome via podocyte cytoskeletal dysfunction.J Med Genet202642209213PubTator, text miningPubMed
Human Pluripotent Stem Cell-Derived Macrophages Modify Development of Human Kidney Organoids: A Preliminary Study.Nephron202642207751PubTator, text miningPubMed
Vascular Endothelial Growth Factor and Placental Growth Factor in Conjunction with Vascular Endothelial Growth Factor Receptor-1 May Exert Dual Effects Within the Kidney and Brain in Patients with Type 2 Diabetes Mellitus and Normoalbuminuric Diabetic Kidney Disease.
Int J Mol Sci202642123337PubTator, text miningPubMed
Characterization of synaptopodin in striated and smooth muscles: isoform spectrum, expression patterns, localization and protein interactions.Exp Cell Res202641941933PubTator, text miningPubMed

1 to 10 of 1,462

See all 1,462 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/11346

GET https://conductscience.org/api/genes/v1/11346/patents